Buradasınız

SELF MICRO EMULSIFYING DRUG DELIVERY SYSTEM (SMEDDS): A REVIEW

Journal Name:

Publication Year:

Abstract (2. Language): 
Oral route is the most convenient route of drug administration, being non invasive, cost effective, thereby leading worldwide drug delivery market. But major problem encountered in oral formulations, is low bioavailability, giving rise to further problems like, high inter and intra subject variability, lack of dose uniformity and finally leading to therapeutic failure. For the therapeutic delivery of lipophillic drugs (BCS class II drugs), lipid based formulations are inviting increasing attention Number of technological strategies are investigated for improving bioavailability like solid dispersions, cyclodextrins, micronization etc. But Self-microemulsifying Drug Delivery System (SMEDDS) have gained exposure for their ability to increase solubility and bioavailability of poorly aqueous soluble drugs with reduction in dose and also drugs are protected from hostile environment in gut. This review gives complete overview of SMEDDS but special attention has been paid to formulation design, evaluation and little emphasis on application of SMEDDS.
664
669

REFERENCES

References: 

1. J. B. Shukla, A. R. Koli, K. M. Ranch, and R. K. Parikh.
Self microemulsifying drug delivery system, An
International Journal of Pharmaceutical Sciences
1(2): 13-33 (2010).
2. A. Chaudhary, U. Nageich, N. Gulati, V. K. Sharma,
and R. L. Khosa. Enhancement of solubilisation and
bioavailability of poorly soluble drugs by physical
and chemical modification- A Recent Review,
Journal of Advanced Pharmacy Education &
Research 2(1): 32-67 (2012).
3. P. Jaiswal, G. Aggrewal, and A. Kaur. Bioavailability
enhancement of poorly soluble drugs by SMEDDS- A
review, Journal of Drug Delivery and Therapeutics
3(1): 98-109 (2013).
4. P. Sudheer, K. M. Nishant, S. Puttachari, M. S.
Umashankar, and R. S. Thakur. Approaches to
development of solid- self micron emulsifying drug
delivery system, formulation techniques and dosage
forms – a review, Asian Journal of Pharmacy and
Life Science 2(2): 214-225 (2012).
5. V. P. Chavda. Are SMEDDs and SNEDDs same? A
gimmick or pharmaceutical relevant, Mintage
Journal of Pharmaceutical & Medical Sciences 1(1):
7-10 (2012).
6. P. Shukla, S. K. Prajapati, U. Sharma, and S. Shivhare.
A review on self micro emulsifying drug delivery
system: An approach to enhance the oral
bioavailability of poorly water soluble drugs,
International Research Journal of Pharmacy 3(9): 1-
6 (2012).
7. A. K. Bansal, K. Sarpal, and Y. B. Pawar. Self
emulsifying drug delivery systems: A strategy to
improve oral bioavailability, Current Research &
Information on Pharmaceutical Science 11(3): 42-
49 (2010).
Vipin et al., ARPB, 2014; Vol 4 (II) ISSN 2250-0774
(REVIEW ARTICLE)
669 | P a g e w w w . a r p b . i n f o
8. A. Kumar, S. Sharma, and R. Kamble. Self
emulsifying drug delivery system (SEDDS): future
aspects, International Journal of Pharmacy and
Pharmaceutical Sciences 2(4): 7-13 (2010).
9. A. Verma, M. K. Singh, and B. Kumar. Development
and characterization of Flutamide containing self
micro emulsifying drug delivery system (SMEDDS),
International Journal of Pharmacy and
Pharmaceutical Sciences 3(4): 60-65 (2011).
10. B. Singh, S. Bandhopadhyaya, K. Rishi, R. Singh and
O. P. Katare. Self emulsifying drug delivery system
(SEDDS): formulation development,
characterization, and applications, Critical™
Reviews in Therapeutic Drug Carrier Systems
26(5): 427-521 (2009).
11. U. Goyal, A. Gupta, and G. Aggrawal. Self
miroemulsifying drug delivery system: A method
for enhancement of bioavailability, International
Journal of Pharmaceutical Sciences and Research
3(1): 66-79 (2012).
12. G. S. Khamkar. Self microemulsifying drug delivery
system (SMEDDS) o/w microemulsion for BCS class
II drugs: An approach to enhance an oral
bioavailability, International Journal of Pharmacy
and Pharmaceutical Sciences 3(3): 1-3 (2011).
13. R. Sachan, K. Khatri, and S. B. Kasture. Self
emulsifying drug delivery system: A novel approach
for enhancement of bioavailability, International
Journal of PharmTech Research 2(3): 1738-1745
(2010).
14. K. S. Preethi, and S. Sharma. Formulation, in vitro
characterization and stability studies of self
microemulsifying drug delivery systems of
Domperidone, International Journal of Innovative
Pharmaceutical Research 1(4): 66-73 (2010).
15. A. M. Babu, B. P. Rao, and P. Sudhakar. Development
and characterization of novel self microemulsifying
drug delivery system of low solubility drug
“Fenofibrate” for improved oral bioavailability,
International Journal of Biological & Pharmaceutical
Research 3(4): 616-623 (2012).
16. C. Raval, N. Joshi, J. Patel, and U. M. Upadhyaya.
Enhanced oral bioavailability of Olmesartan by
using novel solid self emulsifying drug delivery
system, International Journal of Advanced
Pharmaceutics 2(2): 82-92 (2012).
17. M. J. Patel, N. M. Patel, R. B. Patel, and R. P. Patel.
Formulation and evaluation of self
microemulsifying drug delivery system of
Lovastatin, Asian Journal of Pharmaceutical
Sciences 5(6): 266-275 (2010).
18. B. N. Mehta and R. B. Nawale. Glibenclamide loaded
self microemulsifying drug delivery system
(SMEDDS): Development and optimization,
International Journal of Pharmacy and
Pharmaceutical Sciences 5(2): 325-330 (2013).
19. V. B. Patravale, S. D. Mandawgade, S. Sharma, and S.
Pathak. Development of SMEDDS using natural
lipophile: Application of ß- Artemether delivery,
International Journal of Pharmaceutics 362: 179-
183 (2008).
20. K.V. Ramana murthy, S. M. Kumar, and P. Shailaja.
Improvement of oral bioavailability of Nifedipine
through self microemulsifying drug delivery
systems, Journal of Global Trends in Pharmaceutical
Sciences 2(3): 364-388 (2011).
21. A. Deshmukh, and S. Kulkarni. Novel self
microemulsifying drug delivery system of Efavirenz,
Journal of Chemical and Pharmaceutical Research
4(8): 3914-3919 (2012).
22. W. Wu, Y. Wang, and L. Que. Enhanced
bioavailability of silymarin by self microemulsifying
drug delivery system, European Journal of
Pharmaceutics and Biopharmaceutics 6(3): 228-
294 (2006).

Thank you for copying data from http://www.arastirmax.com